The effect of topical application of lavender essential oil on physiological indexes and pain intensity during venous cannulatio

Phase 3

Recruiting

• Conditions: Condition 1: Inguinal hernia. Condition 2: Gallstone.; Inguinal hernia; Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere; K40-k46; K80-k87

• Registration Number: IRCT20171226038078N2
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Patients who are Hospitalized for elective surgery
Patients aged 18 to 65 years old
The patient is completely alert
The patient has the ability to communicate verbally
The patient is not allergic to Iodine and Leukoplast adhesive
There is a suitable vessel in the anterior region of the left hand

Exclusion Criteria

It is not possible to make a venous line at the desired location
The patient used a sedative and anti-anxiety drug for at least 8-6 hours before referral
A patient with Neuropathy, diabetes or other disease that affected on pain perception
The patient has other pain and discomfort before the intravenous line
Patient with psychological disorders based on medical records
The patient is addicted

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain severity score based on the visual scale of pain. Timepoint: Immediately after fixing the angiocate. Method of measurement: Visual Analogue Scale.;Heart rate. Timepoint: Before, immediately, 5 minutes and 10 minutes after completing the intravenous line. Method of measurement: the watch.;Blood Pressure. Timepoint: Before, immediately, 5 minutes and 10 minutes after completing the intravenous line. Method of measurement: Mercury barometric.;Percentage of arterial oxygen saturation. Timepoint: Before, immediately, 5 minutes and 10 minutes after completing the intravenous line. Method of measurement: Pulse oximeter.